SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-46842"
 

Sökning: id:"swepub:oai:DiVA.org:liu-46842" > All-cause mortality...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003065naa a2200373 4500
001oai:DiVA.org:liu-46842
003SwePub
008091011s2002 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-468422 URI
024a https://doi.org/10.1136/jms.9.4.1592 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Tabar, L.4 aut
2451 0a All-cause mortality among breast cancer patients in a screening trial :b Support for breast cancer mortality as an end point
264 c 2016-11-07
264 1b SAGE Publications,c 2002
338 a print2 rdacarrier
520 a Background: It has recently been suggested that all-cause mortality is a more appropriate end point than disease specific mortality in cancer screening trials, and that disease specific mortality is biased in favour of screening. This suggestion is based partly on supposed inconsistencies between all-cause mortality results and disease specific results in cancer screening trials, and alleged increases in deaths from causes other than breast cancer among breast cancer cases diagnosed among women invited to screening. Methods: We used data from the Swedish Two-County Trial of mammographic screening for breast cancer, in which 77 080 women were randomised to an invitation to screening and 55 985 to no invitation. We estimated relative risks (RRs) (invited v control) of death from breast cancer, death from other causes within the breast cancer cases, and death from all causes within the breast cancer cases. RRs were adjusted for age and took account of the longer follow up of breast cancer cases in the invited group due to lead time. Results: There was a significant 31% reduction in breast cancer mortality in the invited group (RR 0.69, 95% confidence interval (Cl) 0.58-0.80, p
653 a NATURAL SCIENCES
653 a NATURVETENSKAP
700a Duffy, S.W.u Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom4 aut
700a Yen, M.-F.u Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom4 aut
700a Warwick, J.u Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdom4 aut
700a Vitak, B.u Östergötlands Läns Landsting,Avdelningen för radiologi US4 aut
700a Chen, H.-H.u Department of Epidemiology, National Taiwan University, Taipei, Taiwan4 aut
700a Smith, R.A.u Department of Cancer Control, American Cancer Society, Atlanta, GA, United States4 aut
710a Dept. of Math., Stat./Epidemiol., Cancer Research UK, London, United Kingdomb Avdelningen för radiologi US4 org
773t Journal of Medical Screeningd : SAGE Publicationsg 9:4, s. 159-162q 9:4<159-162x 0969-1413x 1475-5793
856u http://journals.sagepub.com/doi/pdf/10.1136/jms.9.4.159
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-46842
8564 8u https://doi.org/10.1136/jms.9.4.159

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy